Merit Medical Systems | MMSI - 销售成本



金融业
股票价格
USD
资产
USD 2.72B
现金及等价物
USD 488.08M
销售成本
USD 197.08M
流动资产
USD 1.1B
流动负债
USD 216.87M
债务
USD 821.57M
EBIT
USD 44.16M
EBITDA
USD 97.23M
员工
7.4K
EPS每股收益
USD 0.86
股本和储备
USD 1.63B
销售毛利
USD 184.8M
债务利息支出
USD 6.53M
利息收入
USD 3.9M
贷款资金
USD 735.16M
市值
USD 3.85B
净收入
USD 41M
营业费用
USD 337.72M
营业利润
USD 44.16M
普通股股本
USD 59.66M
PE价格收益
45.2
税前利润
USD 51.06M
销售收入
USD 381.9M
销售和管理费用
USD 110.47M
股票
USD 352.39M
贸易债权人
USD 67.85M
应收帐款人
USD 227M


销售成本 更改 日
3M USD 3.57B 501M 2026-03
Abbott USD 5.3B 380M 2026-03
AngioDynamics USD 37.29M 786K 2025-09
Anika Therapeutics USD 11.44M 797K 2025-12
AtriCure USD 31.94M 3.22M 2026-03
Baxter International USD 1.81B 587M 2026-03
Becton, Dickinson and Co. USD 2.56B 281M 2026-03
Boston Scientific USD 1.83B 8M 2026-03
Cooper Companies USD 393.8M 17M 2026-03
Dexcom USD 441.6M 25.3M 2026-03
Edwards Lifesciences USD 362.6M 19.6M 2026-03
Globus Medical USD 263.59M 26.88M 2026-03
Haemonetics USD 136.58M 4.01M 2025-12
ICU Medical USD 337.72M 1.61M 2025-12
Insulet USD 232.7M 17.5M 2026-03
Integra LifeSciences USD 178.71M 14.73M 2026-03
J&J USD 8.07B 103M 2026-03
Medtronic USD 3.8B 195M 2026-03
Merit Medical Systems USD 197.08M 1.5M 2026-03
Olympus JPY 102.52B 6.38B 2026-03
Pfizer USD 4.59B 1.7B 2026-03
STAAR Surgical USD 24.66M 10.6M 2026-03
Stryker USD 2.36B 325M 2026-03
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Teleflex USD 240.84M 20.7M 2026-03
Terumo JPY 151.3B 7.86B 2026-03
Zimmer Biomet Holdings USD 738.3M 231.8M 2026-03